Group 1 - AbbVie will announce its full-year and fourth-quarter 2025 financial results on February 4, 2026, before the market opens [1] - A live webcast of the earnings conference call will be hosted at 8 a.m. Central time, accessible through AbbVie's Investor Relations website [1] - An archived edition of the earnings call will be available later on the same day [1] Group 2 - AbbVie's mission focuses on discovering and delivering innovative medicines and solutions for serious health issues, addressing both current and future medical challenges [2] - The company aims to have a significant impact across key therapeutic areas, including immunology, oncology, neuroscience, and eye care, as well as in its Allergan Aesthetics portfolio [2] - Additional information about AbbVie can be found on its official website and social media platforms [2]
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call